XOMA Royalty Corp (XOMA) Form 8-K — May 22, 2026
XOMA Royalty Corporation held its 2026 Annual Meeting of Stockholders on May 21, 2026, where all seven director nominees were elected and all proposals were approved. Shareholders approved an amendment to the 2010 Long Term Incentive Plan, adding 425,000 shares to the reserve and extending the term to 2036, as well as the new 2026 Employee Stock Purchase Plan with 500,000 shares authorized. The filing also confirms that the Board adopted amendments to the Company’s bylaws in connection with the previously disclosed merger agreement with Ligand Pharmaceuticals Incorporated.
Key figures
- Shares Outstanding
- 11915730
- Espp shares authorized
- 500000
- Votes against proposal 3
- 668915
- Incentive plan shares added
- 425000
- Incentive plan total shares
- 5318062
- Votes for directors owen hughes
- 8339874
Price after filing
Close on the filing date to close N calendar days later (from $41.82). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.